Tejaswi Kompala, Senior Director, Clinical Strategy, Teladoc Health and Robert Hsu, Director, Clinical Strategy, Teladoc Health The early stages of any new, clinically impactful drug put pressure on benefit leaders
Association of glucagon-like peptide-1 receptor agonists with cardiovascular and kidney outcomes in type 2 diabetic kidney transplant recipients
In: Rosenthal GA, Janzen DH, editors
Sourcing from manufacturers like WBCIL removes the quality risks that often undermine specialised nutraceutical development
Oh yeah, we've got those
You may have seen some of these brands infiltrating your algorithm and peppering your social media feeds with ads and offers, but that doesnt necessarily mean theyre good products